Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Finerenone for Cardiorenal Protection in Diabetic CKD
NCT07326631Not yet recruiting
- Sponsor
- College of Physicians and Surgeons Pakistan
- Start
- Jan 2026
- Primary completion
- Jun 2026
- Modality
- Small Molecules
01
Overview
Single-arm trial of finerenone in diabetic kidney disease (DKD), sponsored by College of Physicians and Surgeons Pakistan. Primary endpoints: Number of Participants with Renal Function Decline at 6 months, Number of Participants with Heart Failure (HF) Event at 6 months and 4 more. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
finerenone
03
Conditions
diabetic kidney disease (DKD)
Beyond the preview
Go deeper on NCT07326631.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07326631.